Key result
Patients with coronary artery disease had higher mean platelet volume compared to healthy controls, which decreased after 7 days of treatment.
Why the study?
The study was conducted to delineate the relations between various platelet volume indices and their role in coronary heart disease.
Do platelet volume indices differ in patients with coronary artery disease compared to healthy controls, and do they change after treatment?
Observational (n=180)
No
Do platelet volume indices differ in patients with coronary artery disease compared to healthy controls, and do they change after treatment?
Platelet volume indices are significantly elevated in patients with coronary artery disease, decrease following treatment, and may serve as prognostic markers for in-hospital mortality.
Answers are grounded in this paper and cite their sources.
Suggests mean platelet volume may serve as a dynamic biomarker in coronary artery disease; leaves open whether.
Background: Various relations have been found out regarding the role of platelets in thrombosis and coronary heart disease. This study is an earnest attempt to delineate the relations between the various platelet volume indices (PVI) and their role in coronary heart disease. Method: During the study period of April 2014 to March 2015, total 180 subjects were studied. Out of them 120 were cases and 60 were controls. The cases of coronary artery disease were divided in to two groups A and B, according to their treatment. Group A included 60 patients with acute coronary syndromes, mainly AMI and UA with medical treatment. Group B included 60 patients with any percutaneous coronary interventions (PCI) for previous ischemic event. Group C included 60 healthy individuals from health check-up unit. A brief and relevant clinical history and laboratory investigations will be taken on the prepared Performa for the subjects. The EDTA and plain samples of 180 subjects were processed in the Central Diagnostic Laboratory. Results: The present study showed higher PVI in the group A and group B when compared to the control group. MPV, PDW and P-LCR were signicantly reduced after treatment in both groups A and B. The mortality was more in those with higher PVI. Conclusion: Coronary artery disease is associated with signicant morbidity and mortality. Platelet volume indices in histograms are easily generated by automated cell counter. Thus, by assessment of it we can predict an impending coronary event. We can prevent reinfarction by monitoring of it. The risk of acute coronary event is also decreased after treatment.
No takes yet. Share an insight, caveat, or question.
Payal et al. (2021) conducted an observational in Coronary Artery Disease (n=180). Coronary Artery Disease vs. Healthy controls was evaluated on Mean Platelet Volume (MPV) (p=<0.001). Patients with coronary artery disease had higher mean platelet volume compared to healthy controls, which decreased after 7 days of treatment.
Synapse has enriched 10 related papers. Consider them for comparative context: